Concepedia

Xiaolin Wan

XW

Statistics

Publications

21

Citations

2.8K

H-Index

18

Active since

2001

Affiliations

National Institutes of Health(Current)

National Cancer Institute

Center for Cancer Research

Molecular Oncology (United States)

Chongqing University

Xiaolin Wan is an author at National Institutes of Health specializing in molecular oncology, oncology, and medicine.

Publications per year

2001–2024

21

Publications

21

Rapamycin induces feedback activation of Akt signaling through an IGF-1R-dependent mechanism

Xiaolin Wan, B Harkavy, Patrick J. Grohar et al. · Oncogene · 2006 · 747 citations

Life Sciences, Biochemistry, Molecular Biology +12

The membrane-cytoskeleton linker ezrin is necessary for osteosarcoma metastasis

Chand Khanna, Xiaolin Wan, Seuli Bose et al. · Nature Medicine · 2004 · 718 citations

Life Sciences, Cancer Biology, Cell Biology +12

Phosphoprotein Pathway Mapping: Akt/Mammalian Target of Rapamycin Activation Is Negatively Associated with Childhood Rhabdomyosarcoma Survival

Emanuel F. Petricoin, Virginia Espina, Robyn P. Araujo et al. · Cancer Research · 2007 · 252 citations · Full text

Medicine, Cancer Biology, Oncology +17

Rapamycin Inhibits Ezrin-Mediated Metastatic Behavior in a Murine Model of Osteosarcoma

Xiaolin Wan, Arnulfo Mendoza, Chand Khanna et al. · Cancer Research · 2005 · 218 citations · Full text

Medicine, Oncology, Pharmacology +10

CCI-779 Inhibits Rhabdomyosarcoma Xenograft Growth by an Antiangiogenic Mechanism Linked to the Targeting of mTOR/Hif-1α/VEGF Signaling

Xiaolin Wan, Na Shen, Arnulfo Mendoza et al. · Neoplasia · 2006 · 146 citations · Full text

Medicine, Oncology, Pharmacology +17

1–5 of 21